Evidence map›Paper›PMID 29267892›Full record

ArticleThe Journal of infectious diseases2018

Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I-Related Molecule-Dependent and Cytokine-Driven Pathways.

Ayako Kurioka, Bonnie van Wilgenburg, Reza Rezaei Javan, Ryan Hoyle, Andries J van Tonder, Caroline L Harrold, Tianqi Leng, Lauren J Howson, Dawn Shepherd, Vincenzo Cerundolo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. MAIT Cell Activation and Functions.Frontiers in immunology · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ayako KuriokaNuffield Department of Medicine, University of Oxford, Oxford.
Bonnie van WilgenburgNuffield Department of Medicine, University of Oxford, Oxford.
Reza Rezaei JavanNuffield Department of Medicine, University of Oxford, Oxford.
Ryan HoyleNuffield Department of Medicine, University of Oxford, Oxford.
Andries J van TonderNuffield Department of Medicine, University of Oxford, Oxford.
Caroline L HarroldNuffield Department of Medicine, University of Oxford, Oxford.
Tianqi LengNuffield Department of Medicine, University of Oxford, Oxford.
Lauren J HowsonMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford.
Dawn ShepherdMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford.
Vincenzo CerundoloMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford.
Angela B BrueggemannNuffield Department of Medicine, University of Oxford, Oxford.
Paul KlenermanNuffield Department of Medicine, University of Oxford, Oxford.
University of Oxford · GBInstitute of Molecular Medicine · INMRC Human Immunology Unit · GB

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Cancer Research UK 11331Cancer Research UK 17722Cancer Research UK C399/A2291Department of HealthNIAID NIH HHS U19 AI082630Wellcome Trust 04992/Z/14/ZWellcome Trust 083511/Z/07/ZWellcome Trust 109965/Z/15/ZWellcome Trust WT109965MA
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells represent an innate T-cell population that can recognize ligands generated by the microbial riboflavin synthesis pathway, presented via the major histocompatibility complex class I-related molecule (MR1). Streptococcus pneumoniae is a major human pathogen that is also associated with commensal carriage; thus, host control at the mucosal interface is critical. The recognition of pneumococci by MAIT cells has not been defined nor have the genomics and transcriptomics of the riboflavin operon. We observed robust recognition of pneumococci by MAIT cells, using both MR1-dependent and MR1-independent pathways. The pathway used was dependent on the antigen-presenting cell. The riboflavin operon was highly conserved across a range of 571 pneumococci from 39 countries, dating back to 1916, and different versions of the riboflavin operon were also identified in related Streptococcus species. These data indicate an important functional relationship between MAIT cells and pneumococci.

Indexed as

Cells, CulturedCytokinesGenes, MHC Class IGenome, BacterialHumansImmunity, CellularMacrophagesMucosal-Associated Invariant T CellsOperonRiboflavinStreptococcus pneumoniaeUp-RegulationCytokinesRiboflavin

Identifiers

PMID29267892
PMCPMC5854017
OpenAlexW2730100455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.